This Article Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (30) Citing Articles via Google Scholar Google Scholar Articles by Huskamp, H. A. Articles by Newhouse, J. P. Search for Related Content PubMed PubMed Citation Articles by Huskamp, H. A. Articles by Newhouse, J. P. Related Collections Managed Care - Medicare Medicare Pharmaceuticals

Health Affairs, Vol 19, Issue 2, 8-23
Copyright © 2000 by Project HOPE

Journal Article

The Medicare prescription drug benefit: how will the game be played?

Most recent proposals to add a prescription drug benefit to the Medicare program suggest using pharmacy benefit managers (PBMs) to control costs and promote quality. However, the proposals give little detail on the institutional arrangements that would govern PBM operations and drug procurement. The recent Congressional Budget Office cost estimate of the Clinton administration's proposal reflects this lack of detail on how PBMs would function. We sketch an approach for structuring PBM operations that focuses on competition among PBMs, manufacturers, and distributors; incentive pricing; and risk sharing with PBMs.

                      What's this?

This article has been cited by other articles:

				J. M. Wiener, W. L. Anderson, and G. Khatutsky Are Consumer-Directed Home Care Beneficiaries Satisfied? Evidence From Washington State Gerontologist, December 1, 2007; 47(6): 763 - 774. [Abstract] [Full Text] [PDF]

				L. H. Curtis, T. Ostbye, V. Sendersky, S. Hutchison, P. E. Dans, A. Wright, R. L. Woosley, and K. A. Schulman Inappropriate Prescribing for Elderly Americans in a Large Outpatient Population Arch Intern Med, August 9, 2004; 164(15): 1621 - 1625. [Abstract] [Full Text] [PDF]

				U. E. Reinhardt, P. S. Hussey, and G. F. Anderson U.S. Health Care Spending In An International Context Health Aff., May 1, 2004; 23(3): 10 - 25. [Abstract] [Full Text] [PDF]

				S. Schneeweiss, A. M. Walker, R. J. Glynn, M. Maclure, C. Dormuth, and S. B. Soumerai Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors N. Engl. J. Med., March 14, 2002; 346(11): 822 - 829. [Abstract] [Full Text] [PDF]

				S. S. Wallack, M. Sciegaj, and L. Long Short- and Intermediate-Term Trends Affecting Medicaid Policy for Persons with Disability, Chronic Illness, and Special Needs Journal of Disability Policy Studies, January 1, 2002; 12(4): 236 - 242. [Abstract] [PDF]

				E. L. Wegner Restructuring Care for the Elderly in Germany Current Sociology, May 1, 2001; 49(3): 175 - 188. [Abstract] [PDF]

				J. K. Iglehart Medicare and Prescription Drugs N. Engl. J. Med., March 29, 2001; 344(13): 1010 - 1015. [Full Text] [PDF]